Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed and Refractory Peripheral T-cell Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT00020865
What this trial is testing

Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia

Who this might be right for
Fever, Sweats, and Hot FlashesInfectionLeukemia+3 more
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00818961
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+1 more
Northside Hospital, Inc. 36
Testing effectiveness (Phase 2)Looking for participantsNCT06420076
What this trial is testing

Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD5/CD7-Specific CAR-T Cells

Who this might be right for
T Cell LymphomaT Cell LeukemiaT-cell Acute Lymphoblastic Leukemia+3 more
Essen Biotech 60
Not applicableWithdrawnNCT00900120
What this trial is testing

Collecting and Storing Blood Samples From Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
University of Medicine and Dentistry of New Jersey
Testing effectiveness (Phase 2)Ended earlyNCT00667017
What this trial is testing

RFT5-dgA Immunotoxin in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
University of Texas Southwestern Medical Center 1
Testing effectiveness (Phase 2)UnknownNCT01307592
What this trial is testing

Gemcitabine Hydrochloride, Rituximab, Oxaliplatin, and Lenalidomide in Treating Patients With Relapsed or Refractory, Aggressive Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
Auxilio Mutuo Cancer Center 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07209163
What this trial is testing

Combination Therapy With Tazemetostat in Relapsed and Refractory Peripheral T-cell Lymphoma

Who this might be right for
Peripheral T Cell Lymphoma
Ruijin Hospital 48
Not applicableStudy completedNCT00408681
What this trial is testing

Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more
Fred Hutchinson Cancer Center 20
Early research (Phase 1)Ended earlyNCT05983965
What this trial is testing

Study of Tazemetostat in Lymphoid Malignancies

Who this might be right for
T-cell Lymphoma
University of Alabama at Birmingham 6
Early research (Phase 1)Looking for participantsNCT06508463
What this trial is testing

Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma

Who this might be right for
Peripheral T Cell LymphomaRelapsed Peripheral T-Cell LymphomaPeripheral T-Cell Lymphoma, Not Otherwise Specified+4 more
Mayo Clinic 21
Testing effectiveness (Phase 2)Study completedNCT02362997
What this trial is testing

Pembrolizumab After ASCT for Hodgkin Lymphoma, DLBCL and T-NHL

Who this might be right for
Hodgkin LymphomaDiffuse Large B Cell LymphomaPeripheral T-Cell Lymphoma
Dana-Farber Cancer Institute 82
Very early researchLooking for participantsNCT07162012
What this trial is testing

Safety and Efficacy of Anti-EBV Autologous TCR-T Cell Injection in Relapsed/Refractory EBV-Positive Lymphoma

Who this might be right for
NK/T-cell LymphomaPeripheral T-cell Lymphoma (PTCL)DLBCL
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 24
Early research (Phase 1)Study completedNCT01767766
What this trial is testing

Evaluate the Safety and Efficacy of TGR 1202 in Patients With Relapsed or Refractory Hematologic Malignancies

Who this might be right for
Non-Hodgkin's LymphomaChronic Lymphocytic LeukemiaPeripheral T-Cell Lymphoma+1 more
TG Therapeutics, Inc. 90
Testing effectiveness (Phase 2)Study completedNCT00182637
What this trial is testing

Bortezomib in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma

Who this might be right for
Lymphoma
Jonsson Comprehensive Cancer Center 5
Testing effectiveness (Phase 2)Study completedNCT02497131
What this trial is testing

Study on the Role of Brentuximab Vedotin as Single Agent in the Treatment of Relapsed/Refractory CD30+ PTCL Patients

Who this might be right for
Lymphatic Diseases
Fondazione Italiana Linfomi - ETS 25
Testing effectiveness (Phase 2)Study completedNCT00448201
What this trial is testing

Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
UNC Lineberger Comprehensive Cancer Center 71
Large-scale testing (Phase 3)Study completedNCT00078949
What this trial is testing

Chemotherapy Before Autologous Stem Cell Transplantation +/- Rituximab in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
NCIC Clinical Trials Group 849
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07758491
What this trial is testing

A Phase I/II Study of FG-M131 in TRBC1+ Relapsed/Refractory Peripheral T-Cell Lymphoma

Who this might be right for
PTCLTRBC1 ADCCTCL
FutureGen Biopharmaceutical (Beijing) Co., Ltd 110
Not applicableLooking for participantsNCT07072221
What this trial is testing

Bendamustine Combined With Chidamide and Lenalidomide for Relapsed and Refractory PTCL Patients

Who this might be right for
Peripheral T-cell Lymphoma
The First Affiliated Hospital of Soochow University 40
Early research (Phase 1)Study completedNCT01588015
What this trial is testing

Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+123 more
City of Hope Medical Center 36
Next Page